These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10150308)

  • 21. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hormone replacement therapy in postmenopausal women and cardiovascular risk].
    Karam C; Bourmayan C; Desnos M; Guérot C
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):195-201. PubMed ID: 7632028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time for new long-term trials of postmenopausal hormone therapies!
    MacLennan A; Sturdee DW
    Climacteric; 2003 Dec; 6(4):265-7. PubMed ID: 15006246
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of estrogens and progestogens on the lipid profile in postmenopausal hypogonadism].
    García L; Hernández I; Cervera Aguilar R; Ayala AR
    Ginecol Obstet Mex; 2001 Sep; 69():351-4. PubMed ID: 11816532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal estrogen use affects risk for Parkinson disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Arch Neurol; 2004 Jun; 61(6):886-8. PubMed ID: 15210525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T; Jaillon P
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone-replacement therapy--time for a reappraisal?
    Brinton LA; Schairer C
    N Engl J Med; 1997 Jun; 336(25):1821-2. PubMed ID: 9187074
    [No Abstract]   [Full Text] [Related]  

  • 32. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
    Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
    Chew S; Ng SC
    Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
    Klein KP; Herrington DM
    Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.
    Hodis HN; Mack WJ; Lobo RA
    Circulation; 2003 Jul; 108(1):e5; author reply e5. PubMed ID: 12847059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.